Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2026 12:00 ET | Source: Research and Markets

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Research Report 2026: Opportunities, Trends, Competitive Landscape, Strategies, Forecasts 2020-2035

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2026" has been added to ...
April 30, 2026 11:57 ET | Source: Research and Markets

Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Research Report 2026: $121 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts 2020-2035

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Report 2026" has been added to ResearchAndMarkets.com's offering. ...
April 30, 2026 11:54 ET | Source: Research and Markets

Peptide and Oligonucleotide CDMO Market Research Report 2026: $4+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Peptide and Oligonucleotide CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The peptide and oligonucleotide DMO...
April 30, 2026 11:38 ET | Source: Research and Markets

Sterile Injectables CDMO Market Research Report 2026: $10.91 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Sterile Injectables CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The sterile injectables CDMO market is...
April 30, 2026 08:00 ET | Source: Integer Holdings Corporation

Integer Holdings Corporation Reports First Quarter 2026 Results

~ First quarter results in line with February outlook ~ ~ Updates 2026 outlook ranges; continues to expect 200bps above-market organic sales growth in 2027 ~ PLANO, Texas, April 30, 2026 ...
April 30, 2026 08:00 ET | Source: Integer Holdings Corporation

Integer Announces Strategic Review to Maximize Stockholder Value

PLANO, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today...
April 30, 2026 07:03 ET | Source: Research and Markets

mRNA Therapeutics CDMO Market Analysis Report 2026: $8.25+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The mRNA therapeutics CDMO market is experiencing...
April 29, 2026 11:19 ET | Source: Research and Markets

Biologics CDMO Research Report 2026: $48.07 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Biologics CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The biologics CDMO market is experiencing tremendous...
April 29, 2026 11:18 ET | Source: Research and Markets

Small Molecule Innovator CDMO Research Report 2026: $93.12 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator CDMO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The small molecule innovator CDMO market...
April 29, 2026 08:00 ET | Source: Integer Holdings Corporation

Integer to Participate in Bank of America Healthcare Conference on May 12

PLANO, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced...